J&J's Cypher Beats Medtronic Endeavor Stent In SORT-OUT III: Does It Matter?
This article was originally published in The Gray Sheet
Executive Summary
Johnson & Johnson's Cypher sirolimus-eluting stent decidedly outperformed Medtronic'sEndeavor zotarolimus-eluting stent in 18-month, head-to-head data reported last week at the American College of Cardiology annual meeting